Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica (Q37107855)

18 August 2017

1 reference

title

Mechanisms of disease: aquaporin-4 antibodies in neuromyelitis optica (English)

1 reference

18 August 2017

1 reference

5

Frauke Zipp

0 references

Friedemann Paul

object named as

Friedemann Paul

2

0 references

Angela Vincent

7

object named as

Angela Vincent

1 reference

18 August 2017

1

Sven Jarius

1 reference

18 August 2017

8

Brigitte Wildemann

1 reference

18 August 2017

Diego Franciotta

3

1 reference

18 August 2017

Patrick Waters

4

1 reference

18 August 2017

Reinhard Hohlfeld

6

1 reference

18 August 2017

11 March 2008

1 reference

Nature Clinical Practice Neurology

18 August 2017

1 reference

18 August 2017

4

1 reference

18 August 2017

4

1 reference

18 August 2017

202-214

1 reference

https://scigraph.springernature.com/pub.10.1038/ncpneuro0764

18 August 2017

0 references

cites work

A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Antibody to aquaporin 4 in the diagnosis of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

NMO-IgG in the diagnosis of neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Revised diagnostic criteria for neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

The clinical course of neuromyelitis optica (Devic's syndrome).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Brain abnormalities in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Devic's neuromyelitis optica: clinical, laboratory, MRI and outcome profile.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

A secondary progressive clinical course is uncommon in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Clinical, CSF, and MRI findings in Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Clinical and MRI features of Japanese patients with multiple sclerosis positive for NMO-IgG.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Neuromyelitis optica in the elderly

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

MR imaging of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Spinal-cord MRI in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Multiple sclerosis in the spinal cord: MR appearance and correlation with clinical parameters

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Discriminative analysis of relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis based on two-dimensional histogram from diffusion tensor imaging.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Grading cervical cord damage in neuromyelitis optica and MS by diffusion tensor MRI.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Brain magnetic resonance imaging findings in relapsing neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Cerebrospinal fluid findings in Devic's neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Oligoclonal bands in Devic's neuromyelitis optica and multiple sclerosis: differences in repeated cerebrospinal fluid examinations

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Detection of the 14-3-3 protein in the cerebrospinal fluid of Japanese multiple sclerosis patients presenting with severe myelitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Neuromyelitis optica (Devic's syndrome) as first manifestation of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Neuromyelitis optica IgG status in acute partial transverse myelitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

cDNA cloning, gene organization, and chromosomal localization of a human mercurial insensitive water channel. Evidence for distinct transcriptional units

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

The human AQP4 gene: definition of the locus encoding two water channel polypeptides in brain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Molecular characterization of an aquaporin cDNA from brain: candidate osmoreceptor and regulator of water balance

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Implications of the aquaporin-4 structure on array formation and cell adhesion.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

The molecular basis of water transport in the brain

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Specialized membrane domains for water transport in glial cells: high-resolution immunogold cytochemistry of aquaporin-4 in rat brain.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Low-dose corticosteroids reduce relapses in neuromyelitis optica: a retrospective analysis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Generation and phenotype of a transgenic knockout mouse lacking the mercurial-insensitive water channel aquaporin-4.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Anchoring of aquaporin-4 in brain: molecular mechanisms and implications for the physiology and pathophysiology of water transport

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Formation of the neuromuscular junction. Agrin and its unusual receptors

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Aquaporin-4 deletion in mice reduces brain edema after acute water intoxication and ischemic stroke.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Delayed K+ clearance associated with aquaporin-4 mislocalization: phenotypic defects in brains of alpha-syntrophin-null mice

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Unravelling the pathogenesis of myasthenia gravis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

'The marvellous harmony of the nervous parts': the origins of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

OSMS is NMO, but not MS: proven clinically and pathologically

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

HLA-DP-associated susceptibility to the optico-spinal form of multiple sclerosis in the Japanese

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

HLA-dPB1*0501 is not uniquely associated with opticospinal multiple sclerosis in Japanese patients. Important role of DPB1*0301

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Devic's neuromyelitis optica: a clinicopathological study of 8 patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Neural-immune interface in the rat area postrema

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

The circumventricular organs participate in the immunopathogenesis of experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

The neurobiology of glia in the context of water and ion homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Activation of humoral immunity and eosinophils in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Establishment of a new sensitive assay for anti-human aquaporin-4 antibody in neuromyelitis optica.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Enhanced expression of aquaporin 4 in human brain with inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Astrocyte characterization in the multiple sclerosis glial scar

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Early glial responses in murine models of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Immune agents for the treatment of Devic's neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Diagnosis and treatment of neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Lymphocytaplasmapheresis in Devic's syndrome

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Fulminant Devic disease successfully treated by lymphocytapheresis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Plasma exchange for severe attacks of CNS demyelination: predictors of response

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

An open label study of the effects of rituximab in neuromyelitis optica

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease).

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Absence of aquaporin-4 expression in lesions of neuromyelitis optica but increased expression in multiple sclerosis lesions and normal-appearing white matter

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Identification of new serum autoantibodies in neuromyelitis optica using protein microarrays

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Magnetic resonance imaging of the head in the diagnosis of multiple sclerosis: a prospective 2-year follow-up with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEURO0764

7 January 2021

Identifiers

DOI

10.1038/NCPNEURO0764

1 reference

Dimensions Publication ID

18 August 2017

0 references

1 reference